Cathie Wood Intellia Therapeutics, Inc. Transaction History
Ark Investment Management LLC
- $10.5 Billion
- Q3 2024
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 12,255,440 shares of NTLA stock, worth $148 Million. This represents 2.39% of its overall portfolio holdings.
Number of Shares
12,255,440
Previous 11,595,789
5.69%
Holding current value
$148 Million
Previous $260 Million
2.95%
% of portfolio
2.39%
Previous 2.36%
Shares
32 transactions
Others Institutions Holding NTLA
# of Institutions
314Shares Held
91.5MCall Options Held
442KPut Options Held
880K-
Vanguard Group Inc Valley Forge, PA9.63MShares$116 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$116 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$62 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$59.6 Million3.75% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$38 Million0.05% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $916M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...